Colony Bankcorp (CBAN) Q3 2025 Earnings Transcript

Colony Bankcorp posted solid Q3 operating improvement, with net interest margin up 5 bps sequentially and 53 bps year over year, operating ROA rising to 1.06% from 0.81%, and tangible book value per share increasing to $14.20. Loan growth remained strong at 9% annualized for the quarter and about 14% YTD, while deposits rose $28.1 million and the board declared a $0.115 quarterly dividend. Credit trends were mixed, with $900,000 of provision expense, higher SBSL charge-offs, and a disputed $1.25 million wire-fraud-related insurance loss, but management said charge-offs have peaked and the TC Bancshares merger remains on track for Q4 closing.

Analysis

CBAN is turning the rate cycle into a visible earnings lever, but the more interesting point is that this quarter likely marks the last easy leg of the reprice story. Loan yields are still catching up to funding costs, yet management is already signaling growth normalization, which means incremental NIM upside should decelerate while operating leverage becomes the main driver. That usually compresses the multiple on banks that were previously rewarded for accelerating margin expansion.

The cleaner takeaway is that earnings quality is improving through mix shift: fee-heavy businesses and wealth/insurance are starting to matter enough to offset softness in mortgage and SBA. That diversification reduces cyclicality, but it also changes how investors should underwrite the name — this is less a pure spread bank and more a slow-burn compounding story with episodic fee monetization. The small one-time fintech gain and securities-sale earn-back suggest management is actively manufacturing near-term EPS, which helps, but those are not durable anchors for valuation.

Credit is the swing factor over the next 1-2 quarters. Management’s confidence around SBSL charge-offs peaking is helpful, but the market will likely wait for hard evidence in the next vintage before giving full credit for it; if criticized and NPAs keep inching higher, the stock can lag even if headline earnings hold. The merger with TC adds upside optionality, but it also brings a near-term integration and expense overhang just as core loan growth is slowing.

Contrarian view: the market may be too focused on the good margin print and not enough on the fact that the easy funding beta and high-growth phase are both fading simultaneously. If municipal deposits rebound as expected, liquidity improves, but excess cash plus slower loan demand can mute incremental NII. In that setup, CBAN may be a better hold than a chase: upside remains, but the next catalyst has to be execution on TC integration and evidence that fee businesses can re-rate the earnings base.

Key Decisions for Investors

• Go long CBAN on pullbacks over the next 2-6 weeks, but size as a hold-to-earnings compounding trade rather than a momentum trade; upside comes from TC close + fee mix, while downside is limited if credit stabilizes.
• Sell near-dated upside calls against a CBAN long into the merger window (covered call into 1Q26) to monetize the likely compression in margin-expansion narrative while retaining dividend carry.
• Pair trade: long CBAN / short a pure spread-sensitive bank with slower fee diversification over the next 1-2 quarters; CBAN has better mix and a clearer catalyst path, but only if credit doesn’t deteriorate.
• Avoid chasing the stock ahead of the next credit print; if SBSL charge-offs or NPAs tick higher again, expect a 10-15% de-rating before the merger synergies can matter.
• If TC integration milestones are missed or expense saves slip past 2Q26, reduce exposure quickly; the market will not pay up for a bank story that loses its margin narrative before synergies arrive.